找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊Drug Testing and Analysis 2024/2025影响因子:2.666 (DRUG TEST ANAL) (1942-7603). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scie  ...234
Total Citations:4060; 2023 JIF:2.666; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:2.406; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:1; Immediacy Index-dealt:1.137; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:158; JCI Quartile:Q2; JCI Percentile:64.62; Eigenfactor:0.004; Normalized Eigenfactor:0.818; Article Influence Score:0.501; JIF Percentile:50.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:166; % of Articles in Citable items:0.9518; Cited Half-Life:5.1; Citing Half-Life:7.1; % of OA Gold:0.3542; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 SCIE期刊CURRENT PHARMACEUTICAL BIOTECHNOLOGY 2024/2025影响因子:2.286 (CURR PHARM BIOTECHNO) (1389-2010). (PHARMACOLOGY & PHAR  ...234
Total Citations:4487; 2023 JIF:2.286; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:2.486; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:1.2; Immediacy Index-dealt:1.297; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:53; JCI Quartile:Q3; JCI Percentile:34.6; Eigenfactor:0.002; Normalized Eigenfactor:0.484; Article Influence Score:0.381; JIF Percentile:42.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:139; % of Articles in Citable items:0.3813; Cited Half-Life:7.7; Citing Half-Life:7.3; % of OA Gold:0.0066; Publisher name:ACADLORE PUBLISHING HOUSE; Publisher address:No. 12, Floor 12, Ho King Comm
投票 SCIE期刊Expert Opinion on Orphan Drugs 2024/2025影响因子:0.851 (EXPERT OPIN ORPHAN D) (2167-8707). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:339; 2023 JIF:0.851; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:0.762; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:<0.1; Immediacy Index-dealt:0.033; 2023 JCI:0.14; JCI Rank: 330/354 ; Total Articles:2; JCI Quartile:Q4; JCI Percentile:6.92; Eigenfactor:0; Normalized Eigenfactor:0.085; Article Influence Score:0.268; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:3; % of Articles in Citable items:0.6667; Cited Half-Life:7; Citing Half-Life:9.4; % of OA Gold:0.3077; Publisher name:CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC; Publisher address:Editorial CSIC,
投票 SCIE期刊NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 2024/2025影响因子:3.149 (N-S ARCH PHARMACOL) (0028-1298). (PHARMACOLOGY  ...234
Total Citations:6530; 2023 JIF:3.149; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.133; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.6; Immediacy Index-dealt:0.666; 2023 JCI:0.9; JCI Rank: 101/354 ; Total Articles:399; JCI Quartile:Q2; JCI Percentile:71.61; Eigenfactor:0.004; Normalized Eigenfactor:0.836; Article Influence Score:0.533; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:513; % of Articles in Citable items:0.7778; Cited Half-Life:7.3; Citing Half-Life:7; % of OA Gold:0.2266; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊DRUG SAFETY 2024/2025影响因子:4.159 (DRUG SAFETY) (0114-5916). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Inde  ...234
Total Citations:6549; 2023 JIF:4.159; JIFRank: 82/354 ; Rank-JIF: 82; Number-of-JIF:354; 5 Year JIF:4.195; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.7; Immediacy Index:0.7; Immediacy Index-dealt:0.788; 2023 JCI:1.01; JCI Rank: 80/354 ; Total Articles:88; JCI Quartile:Q1; JCI Percentile:76.55; Eigenfactor:0.005; Normalized Eigenfactor:1.153; Article Influence Score:1.203; JIF Percentile:86.2; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:96; % of Articles in Citable items:0.9167; Cited Half-Life:9.4; Citing Half-Life:6.1; % of OA Gold:0.542; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 SCIE期刊PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2024/2025影响因子:5.304 (PROG NEURO-PSYCHOPH) (0278-5846  ...234
Total Citations:14042; 2023 JIF:5.304; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:4.988; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.1; Immediacy Index:0.7; Immediacy Index-dealt:0.722; 2023 JCI:1.43; JCI Rank: 28/354 ; Total Articles:143; JCI Quartile:Q1; JCI Percentile:87.9; Eigenfactor:0.015; Normalized Eigenfactor:3.265; Article Influence Score:1.407; JIF Percentile:86; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:160; % of Articles in Citable items:0.8938; Cited Half-Life:6.9; Citing Half-Life:8.4; % of OA Gold:0.1991; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, M
投票 SCIE期刊Fitoterapia 2024/2025影响因子:2.524 (FITOTERAPIA) (0367-326X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Inde  ...234
Total Citations:11324; 2023 JIF:2.524; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.788; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.5; Immediacy Index-dealt:0.507; 2023 JCI:0.75; JCI Rank: 144/354 ; Total Articles:244; JCI Quartile:Q2; JCI Percentile:59.46; Eigenfactor:0.005; Normalized Eigenfactor:1.028; Article Influence Score:0.432; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:284; % of Articles in Citable items:0.8592; Cited Half-Life:9.2; Citing Half-Life:7.3; % of OA Gold:0.0655; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD
投票 SCIE期刊European Journal of Hospital Pharmacy 2024/2025影响因子:1.669 (EUR J HOSP PHARM) (2047-9956). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:1268; 2023 JIF:1.669; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:1.718; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.3; Immediacy Index-dealt:0.386; 2023 JCI:0.47; JCI Rank: 250/354 ; Total Articles:73; JCI Quartile:Q3; JCI Percentile:29.52; Eigenfactor:0.002; Normalized Eigenfactor:0.384; Article Influence Score:0.384; JIF Percentile:27; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:78; % of Articles in Citable items:0.9359; Cited Half-Life:3.6; Citing Half-Life:7.2; % of OA Gold:0.1367; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23 We
投票 SCIE期刊PHARMACOECONOMICS 2024/2025影响因子:4.404 (PHARMACOECONOMICS) (1170-7690). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C  ...234
Total Citations:6576; 2023 JIF:4.404; JIFRank: 65/354 ; Rank-JIF: 65; Number-of-JIF:354; 5 Year JIF:4.891; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4; Immediacy Index:0.8; Immediacy Index-dealt:0.886; 2023 JCI:1.23; JCI Rank: 55/354 ; Total Articles:67; JCI Quartile:Q1; JCI Percentile:83.71; Eigenfactor:0.007; Normalized Eigenfactor:1.628; Article Influence Score:1.738; JIF Percentile:88.8; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:103; % of Articles in Citable items:0.6505; Cited Half-Life:7.8; Citing Half-Life:6.5; % of OA Gold:0.6351; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊MEDICINAL RESEARCH REVIEWS 2024/2025影响因子:10.979 (MED RES REV) (0198-6325). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scien  ...234
Total Citations:8632; 2023 JIF:10.979; JIFRank: 10/354 ; Rank-JIF: 10; Number-of-JIF:354; 5 Year JIF:12.965; 5 Year JIF Quartile:Q1; JIF Without Self Cites:10.8; Immediacy Index:2.6; Immediacy Index-dealt:2.644; 2023 JCI:1.65; JCI Rank: 21/354 ; Total Articles:1; JCI Quartile:Q1; JCI Percentile:94.21; Eigenfactor:0.008; Normalized Eigenfactor:1.74; Article Influence Score:2.561; JIF Percentile:97.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:73; % of Articles in Citable items:0.0137; Cited Half-Life:4.9; Citing Half-Life:6.8; % of OA Gold:0.1793; Publisher name:NATL CHENGCHI UNIV; Publisher address:NO. 64, SECTION 2, ZHINAN RD, TAIPEI CI
投票 SCIE期刊Bangladesh Journal of Pharmacology 2024/2025影响因子:0.931 (BANGL J PHARMACOL) (1991-007X). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:698; 2023 JIF:0.931; JIFRank: 309/354 ; Rank-JIF: 309; Number-of-JIF:354; 5 Year JIF:1.178; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.5; Immediacy Index:0.5; Immediacy Index-dealt:0.529; 2023 JCI:0.28; JCI Rank: 298/354 ; Total Articles:16; JCI Quartile:Q4; JCI Percentile:15.96; Eigenfactor:0; Normalized Eigenfactor:0.021; Article Influence Score:0.103; JIF Percentile:12.9; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:16; % of Articles in Citable items:1; Cited Half-Life:8.3; Citing Half-Life:9.5; % of OA Gold:0.5111; Publisher name:POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST FUNDAMENTAL TECH RES PAS; Publisher addr
投票 SCIE期刊PHARMACEUTICAL CHEMISTRY JOURNAL 2024/2025影响因子:0.829 (PHARM CHEM J+) (0091-150X). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:2265; 2023 JIF:0.829; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:0.962; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.109; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:202; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.192; Article Influence Score:0.105; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:211; % of Articles in Citable items:0.9573; Cited Half-Life:7.9; Citing Half-Life:8.8; % of OA Gold:0; Publisher name:AME PUBLISHING COMPANY; Publisher address:FLAT-RM C 16F, KINGS WING PLAZA 1, N
投票 SCIE期刊SAUDI PHARMACEUTICAL JOURNAL 2024/2025影响因子:3.124 (SAUDI PHARM J) (1319-0164). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:6152; 2023 JIF:3.124; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.958; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.7; Immediacy Index-dealt:0.778; 2023 JCI:1; JCI Rank: 81/354 ; Total Articles:306; JCI Quartile:Q1; JCI Percentile:77.26; Eigenfactor:0.004; Normalized Eigenfactor:0.911; Article Influence Score:0.573; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:334; % of Articles in Citable items:0.9162; Cited Half-Life:5.2; Citing Half-Life:6.9; % of OA Gold:0.9577; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23 We
投票 SCIE期刊EXPERT OPINION ON PHARMACOTHERAPY 2024/2025影响因子:2.514 (EXPERT OPIN PHARMACO) (1465-6566). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:6538; 2023 JIF:2.514; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:3.396; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.4; Immediacy Index:0.8; Immediacy Index-dealt:0.884; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:41; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.006; Normalized Eigenfactor:1.252; Article Influence Score:0.836; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:152; % of Articles in Citable items:0.2697; Cited Half-Life:7.1; Citing Half-Life:6.5; % of OA Gold:0.0913; Publisher name:CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC; Publisher address:Edito
投票 SCIE期刊EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影响因子:4.389 (EUR J PHARM SCI) (0928-0987). (PHARMACOLOGY & PH  ...234
Total Citations:17502; 2023 JIF:4.389; JIFRank: 69/354 ; Rank-JIF: 69; Number-of-JIF:354; 5 Year JIF:4.246; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:0.8; Immediacy Index-dealt:0.891; 2023 JCI:1.38; JCI Rank: 36/354 ; Total Articles:246; JCI Quartile:Q1; JCI Percentile:89.97; Eigenfactor:0.01; Normalized Eigenfactor:2.164; Article Influence Score:0.66; JIF Percentile:80.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:259; % of Articles in Citable items:0.9498; Cited Half-Life:6.5; Citing Half-Life:7; % of OA Gold:0.6497; Publisher name:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD; Publisher address:24-28 OVAL RD, LOND
投票 SCIE期刊ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES 2024/2025影响因子:1.651 (ASSAY DRUG DEV TECHN) (1540-658X). (PHARMACOLOGY & P  ...234
Total Citations:1298; 2023 JIF:1.651; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:2.219; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.3; Immediacy Index-dealt:0.308; 2023 JCI:0.45; JCI Rank: 254/354 ; Total Articles:28; JCI Quartile:Q3; JCI Percentile:28.39; Eigenfactor:0; Normalized Eigenfactor:0.093; Article Influence Score:0.338; JIF Percentile:27; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:30; % of Articles in Citable items:0.9333; Cited Half-Life:9.4; Citing Half-Life:8.3; % of OA Gold:0.0204; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊BIOPHARM INTERNATIONAL 2024/2025影响因子:0.114 (BIOPHARM INT) (1542-166X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C  ...234
Total Citations:216; 2023 JIF:0.114; JIFRank: 352/354 ; Rank-JIF: 352; Number-of-JIF:354; 5 Year JIF:0.115; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:0.4; Immediacy Index-dealt:0.407; 2023 JCI:0.03; JCI Rank: 350/354 ; Total Articles:21; JCI Quartile:Q4; JCI Percentile:1.27; Eigenfactor:0; Normalized Eigenfactor:0.013; Article Influence Score:0.02; JIF Percentile:0.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:21; % of Articles in Citable items:1; Cited Half-Life:9.3; Citing Half-Life:3; % of OA Gold:0; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊Expert Opinion on Drug Delivery 2024/2025影响因子:5.138 (EXPERT OPIN DRUG DEL) (1742-5247). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:9566; 2023 JIF:5.138; JIFRank: 43/354 ; Rank-JIF: 43; Number-of-JIF:354; 5 Year JIF:7.229; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.8; Immediacy Index:1.1; Immediacy Index-dealt:1.119; 2023 JCI:0.98; JCI Rank: 84/354 ; Total Articles:17; JCI Quartile:Q1; JCI Percentile:76.41; Eigenfactor:0.005; Normalized Eigenfactor:0.993; Article Influence Score:1.146; JIF Percentile:88; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:103; % of Articles in Citable items:0.165; Cited Half-Life:7.8; Citing Half-Life:5.6; % of OA Gold:0.1575; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MIL
投票 SCIE期刊JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 2024/2025影响因子:2.166 (J CLIN PHARM THER) (0269-4727). (PHARMACOLOGY  ...234
Total Citations:4096; 2023 JIF:2.166; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.188; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.041; 2023 JCI:0.46; JCI Rank: 253/354 ; Total Articles:42; JCI Quartile:Q3; JCI Percentile:28.67; Eigenfactor:0.004; Normalized Eigenfactor:0.982; Article Influence Score:0.58; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:55; % of Articles in Citable items:0.7636; Cited Half-Life:6.2; Citing Half-Life:6.5; % of OA Gold:0.7639; Publisher name:BMC; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊Pharmacogenetics and Genomics 2024/2025影响因子:1.707 (PHARMACOGENET GENOM) (1744-6872). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:2393; 2023 JIF:1.707; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.827; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.4; Immediacy Index-dealt:0.419; 2023 JCI:0.57; JCI Rank: 210/354 ; Total Articles:22; JCI Quartile:Q3; JCI Percentile:41.1; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.449; JIF Percentile:28; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:23; % of Articles in Citable items:0.9565; Cited Half-Life:11.9; Citing Half-Life:9.3; % of OA Gold:0.0879; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 13:58
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块